Pioneering theranostics in immuno-oncology, PET radiotracer images T-cell & NK cell activation

A clinical-stage Australian biotech pioneering first-in-class radiopharmaceuticals for diagnostic and therapeutic use. They’re developing multiple theranostic agents targeting PD-L1, HER2, αvβ6 integrin, advanced prostate cancer, brain metastases, and more

Medison focuses on hazardous and healthcare waste and is cited as a key player in the medical waste market, including management of waste contaminated with radionuclides from diagnostic and radiotherapeutic procedures, making it relevant for theranostic nuclear medicine departments

iMing Venture Partners invests in early-stage biotech, including oncology. The firm supports innovative drug development in Asia-Pacific, aligning with growing radiopharma hubs like China.

National professional society for nuclear medicine in India for over 4 decades.

A global medical technology leader offering advanced imaging systems (like PET/CT and PET/MR), molecular diagnostics, and integrated healthcare solutions. They offer Theranostic imaging tools & integrate dosimetry software (Hermia) into their platforms.

Veolia provides international hazardous waste and nuclear services, including radioactive waste management and specialized services for healthcare. Their medical-waste divisions process regulated medical and pharmaceutical waste, and their nuclear / hazardous units manage radioactive materials and LLW.

Harvard Medical School provides advanced certificate programs like Global Clinical Scholars Research Training for clinicians and researchers, focusing on study design, regulatory issues, data management, ethics, and leadership in clinical trials. It prepares international staff for high-level roles in trial management and research.

Global provider of nuclear medicine & diagnostic imaging services operating radiopharmacies, PET & cyclotron services and theranostic offerings.

Offers comprehensive oncology drug development services, including models and assays instrumental in theranostic research—supporting both diagnostics and therapeutics through their deep oncology expertise and global infrastructure

SOCRA offers education, CCRP certification, and workshops on GCP, regulatory compliance, site management, data integrity, and trial operations for clinical research professionals worldwide.

A global contract research organization (CRO) based in Ireland. Also launched integrated theranostic services in Australia.

A full‑service Contract Research Organization (CRO) with offices in the U.S & Australia.

A U.S.-based developer of precision quality control and calibration products for nuclear medicine, particularly SPECT and PET imaging, with worldwide distribution.

CANM is the leading organization for nuclear medicine professionals in Canada, offering education, advocacy, and support for the use of nuclear medicine and theranostics.

Health System Readiness provides a toolkit for patient advocates to promote equitable access to radiopharmaceutical diagnostics and therapies in oncology theranostics. It includes educational FAQs, advocacy strategies, and resources to engage stakeholders and influence policy.

Health System Readiness provides a toolkit for patient advocates to promote equitable access to radiopharmaceutical diagnostics and therapies in oncology theranostics. It includes educational FAQs, advocacy strategies, and resources to engage stakeholders and influence policy.

A Canadian CDMO that specializes in GMP manufacturing of radiopharmaceuticals—including isotopes like Lu-177, Ac-225, I-131, In-111, and Zr-89—enabling both diagnostic and therapeutic applications central to theranostic development.

Medidata is a leading provider of cloud-based SaaS and analytics platforms that support clinical research—from trial design and data capture to patient engagement, AI-powered insights, and decentralized trial technologies

MRP is a Hungarian CDMO specializing in radiopharmaceutical kits, cold kits, and nuclear medicine manufacturing, supplying imaging and potentially theranostic agents globally

Foresite Capital focuses on multi-stage investments in healthcare and life sciences, leveraging biology and big data for transformative therapies

SHINE is a nuclear technology company focused on producing medical isotopes at scale, including high-purity (non-carrier-added) Lutetium-177, a workhorse isotope for radioligand therapy. By expanding reliable supply for therapy isotopes (and related diagnostic isotopes like Mo-99), they support the manufacturing backbone that makes theranostics broadly deployable.

One of Europe’s flagship cancer hospitals with a dedicated Nuclear Medicine & PET/CT department supporting radionuclide imaging and therapy workflows alongside an intensive oncology trial ecosystem.

Fluor is a global EPC/EPCM player that includes life sciences among its markets, making them relevant for large-scale facility programs tied to theranostic supply (manufacturing infrastructure, advanced facility builds). They're most useful when the scope looks like a serious industrialized facility rather than a small clinic refresh.

Triumvirate provides hazardous waste management with a heavy focus on healthcare, life sciences and hospitals. They offer radiation safety management, including consulting on radioactive waste reduction and recycling, and list radioactive materials as part of their lab-pack waste capabilities, which maps neatly to nuclear medicine and radiopharmacy waste streams generated by theranostic programs.

Sanofi is a multi-therapeutic area pharmaceutical giant with a growing interest in radiopharmaceuticals and theranostics through a licensing agreement for lead‑212 radioligand therapy (AlphaMedix™) targeting neuroendocrine tumors

Plus Therapeutics is a U.S. clinical-stage pharmaceutical company developing innovative targeted radiotherapeutics, particularly nanoliposome-encapsulated Rhenium‑186 (Re‑186)

Duke's radiotheranostics program targets prostate and neuroendocrine cancers using radiolabeled molecules for imaging and therapy, including Lutathera (Lu-177 dotatate) for neuroendocrine tumors and Pluvicto (Lu-177 vipivotide tetraxetan) for metastatic castration-resistant prostate cancer. Research includes alpha emitters like Actinium-225, combinations with DNA repair inhibitors, KLK2-targeted agents, and trials like NETTER-1, COMPOSE, and BELU-RE.

UCLA is a major U.S. hub for PSMA/radioligand imaging-to-therapy translation, with prominent leadership driving clinical trials and multi-institutional collaborations.

Kalitta Charters offers on-demand and scheduled air transport for radiopharmaceuticals, specializing in Next Flight Out services for theranostics shipments to ensure viability upon arrival at medical centers

A clinical-stage immuno-oncology imaging company that engineers “minibodies” (antibody fragments) for PET and optical imaging, enabling non-invasive visualization of immune cells (e.g. CD8 T‑cells) and tumor markers—a powerful theranostic tool for patient selection and treatment monitoring in cancer immunotherapy

A Swiss clinical‑stage biotech firm developing novel DARPin (Designed Ankyrin Repeat Protein) therapeutics for oncology. They're advancing a Radio‑DARPin Therapy (RDT) platform—creating targeted radioligand treatments using DARPins to deliver radionuclide payloads

A leading global biopharmaceutical company developing medications and vaccines across oncology

A leading commercial supplier of Copper‑67 (Cu‑67), a high‑specific‑activity therapeutic isotope ideal for theranostic pairings when combined with diagnostic isotopes like Cu‑64 or Cu‑61—offering what's called "perfect theranostic pairs" for precision imaging and therapy

US Ecology, now part of Republic Services, has long been active in low-level radioactive waste and hazardous waste management. They operate specialized treatment and disposal facilities handling radioactive waste, and market services for medical, research and industrial generators, which is relevant for larger nuclear medicine and theranostic production sites

A Tokyo-based biotech focused on peptide discovery (PDPS platform), developing peptide therapeutics and diagnostics—foundational to theranostic innovation.

XCancer Omaha is a community-based oncology and clinical trials center that has built a high-throughput radiopharmaceutical/theranostics trial program, positioning itself as a rapid-start site for early-phase studies. XCancer has conducted hundreds of Phase I–III trials and 20+ first-in-world studies in radiopharmaceuticals/precision oncology, along with "first-in-world / first-in-U.S." prostate cancer treatments highlighted under the XCancer brand.

Gaziantep University has published a single-center Lu-177 PSMA radioligand therapy experience, indicating hands-on theranostic treatment activity (not just theoretical interest).

ITM is a leading radiopharmaceutical biotech and isotope company, globally known for production and supply of therapeutic isotopes like n.c.a. Lu-177 and Ac-225, which are core to many theranostic agents

TTC is explicitly designed for early-phase clinical trials of radiolabeled targeted drugs (diagnosis + therapy), run within Karolinska’s nuclear medicine/hospital physics ecosystem with oncology collaboration.

International Centers for Precision Oncology (ICPO) Foundation is a non‑profit organization. It aims to advance Theranostics by scaling global patient access—through building a network of accredited clinical centers, standardized education & fostering a collaborative international community

A vertically integrated radiopharmaceutical biotech company focused on delivering diagnostic and therapeutic radionuclides, including leading supply of Lu‑177 and Ac‑225 isotopes.

The SNUH academic nuclear medicine ecosystem is heavily involved in molecular imaging and radiopharmaceutical translation, feeding theranostics research and clinical application from imaging through targeted radionuclide approaches.

Theranostic Media Solutions is a social media content creation firm with theranostics as its only focus. Delivers a steady, cadence of LinkedIn posts that translate radiopharmaceutical science into clear, accurate language. Promoting your organization within the theranostic ecosystem.

IBA is a technology provider that helps develop and operate PET radiopharmaceutical production centers, and is a key supplier in radiopharma and theranostic infrastructure

A UPS company excels in time-critical nuclear medicine transportation, offering white glove service for radiopharmaceuticals.

Medrio provides a scalable EDC/CDMS platform with ePRO, eConsent, and RTSM, proven in over 8,000 studies including oncology and therapeutic oncology companies. It supports theranostic trials through flexible data collection for complex protocols, enabling real-time capture of patient outcomes and imaging data essential for radioligand therapy monitoring in cancer studies.

Baker Brothers Advisors is a prominent biotechnology-focused hedge fund that invests heavily in public and private oncology companies, including those in the radiopharmaceutical and theranostic space. It holds significant stakes in leading biotech firms advancing targeted radionuclide therapies, such as Aktis Oncology and ARtBio.

Abingworth, a transatlantic life sciences investor, backed AdvanCell's targeted alpha therapies in 2025, advancing actinium-based radioligands for prostate cancer. This investment supports theranostics by funding vertically integrated radiopharma platforms.

A digital health radiology platform that connects patients, healthcare providers, and pharmaceutical partners to a network of U.S.-based, subspecialty radiologists—offering rapid, expert second‑opinion imaging reads/RECIST (e.g. CT, PET)

NRG Oncology's Patient Advocate Committee engages survivors in research, while its Theranostics Subcommittee supports trials integrating diagnostic and therapeutic radionuclides for cancers. It offers resources for patients on clinical trials involving theranostics.

MedChemExpress is a broad life-science reagent supplier that carries a sizeable catalog of bifunctional chelating agents such as DOTA, NOTA, HBED-CC derivatives, p-SCN-Bn-HOPO, DFO-DBCO and related constructs.

MSK runs a major radiopharmaceutical therapy program spanning targeted imaging + therapy trials (including disease-focused radioligand pipelines) through Nuclear Medicine and its broader clinical trials enterprise

An Australian biotech developing dendrimer-based platforms for drug delivery and imaging agents, with potential theranostic applications, although it's primarily known for its antiviral and topical products.

VIARES offers global online clinical research training programs and certifications for roles such as CRA, CTA, and clinical project manager, covering regulatory compliance, data management, budgeting, and GCP.

Syneos Health offers pharmacokinetic and lab services for early-phase theranostic oncology trials, specializing in radiopharmaceuticals.

IQVIA is a large global CRO / data & technology provider that reports having run more than 25 phase I–IV radiopharmaceutical clinical trials and supports RLT programs with its oncology and imaging infrastructure

Formed in 2021 as a sister company to Blue Earth Diagnostics—is focused on developing next‑generation targeted radiotherapeutics in oncology.

A Siemens Healthineers company, is the world's largest PET radiopharmaceutical network—producing, distributing, and supporting PET tracers critical to the diagnostic side of theranostics, including agents used for patient selection and imaging guidance.

A technology provider in the field of nuclear medicine, specializing in the design, manufacture, and support of advanced radiopharmacy equipment such as synthesizers, dispensers, and quality-control systems for radiopharmaceutical production in research, clinical, and industrial settings

Oracle Life Sciences offers integrated clinical trial solutions, including the Clinical One platform for EDC, randomization, and supply management. They are directly involved in theranostics by providing specialized support for radioligand therapy trials, addressing the unique data needs of radiopharmaceutical developments in cancer treatment.

Operates a large radiopharmaceutical manufacturing network and provides clinical supply, development, and manufacturing services, including for theranostic agents (e.g. FAPI, PSMA).

IRE is a public-utility foundation whose main activity is the production of radioisotopes for diagnostic and therapeutic nuclear medicine, and it is a global leader in fission Mo-99 for Tc-99m generators

A clinical‑stage radiopharmaceutical company pioneering image‑guided alpha-particle targeted therapies (Pb‑212) paired with matching imaging tracers (Pb‑203), forming a true theranostic platform to both visualize and treat cancer

Conference Organizer

Focused on developing a new class of targeted radiopharmaceuticals for solid tumors, putting theranostic principles—pairing diagnostic specificity with therapeutic payload—at the core of their strategy

CCRPS provides accredited online certifications and training for clinical research roles including CRC, CRA, project manager, regulatory affairs, and data management, with modules on GCP, budgeting, contracts, and trial coordination.

A leading radiopharmaceutical company known for products that help clinicians “Find, Fight, Follow” diseases, primarily through diagnostic imaging—and is expanding into radiotherapeutics and theranostics solutions

CheMatech is a chelator specialist and SNMMI-facing player focused on the design and synthesis of macrocyclic chelating agents, especially DOTA, NOTA, NODAGA and related derivatives.

Norroy Bioscience is an R&D-oriented biotech focused on developing and commercializing radiopharmaceutical theranostics, spanning imaging and targeted radiotherapy programs. They also build automated synthesizers and production modules designed to support radiopharmaceutical manufacturing in both R&D and GMP environments, helping enable reliable tracer and therapy supply for theranostic clinical use.

A commercial-stage biopharmaceutical company pioneering theranostic radiopharmaceuticals, developing both diagnostic and therapeutic agents for cancers and rare diseases—such as its FDA-approved PSMA‑PET imaging agent Illuccix®,CAIX for Renal Cell imaging and pipeline expansion into fibroblast activation protein (FAP) targeting for potential broad-spectrum theranostic utility

A German/U.S. MedTech that develops AI-driven software tools for enhanced prostate cancer management for personalized treatment prediction from PSMA PET

Swedish based, developer of vendor‑neutral molecular imaging and dosimetry software—most notably the Hermia platform—that supports PET/SPECT/CT/MR review, quantitative dosimetry (including voxel and organ dosimetry), and theranostics workflows 

NRG PALLAS operates the Petten nuclear infrastructure in the Netherlands, one of the most important reactors in the world for medical isotope production, providing Mo-99/Tc-99m and other isotopes used for millions of patient scans and treatments annually. NRG PALLAS is gearing up the PALLAS reactor to support future growth in therapeutic isotopes for theranostics

JSC Isotope (272): JSC Isotope is a subsidiary of Rosatom and functions as the single industry operator that markets and exports isotope products produced across Rosatom enterprises, supplying over 70% of items in the global medical isotope product line and exporting to roughly 50 countries

GBI is a biologics CDMO with deep history in antibody conjugation, including radiolabeled antibodies used for imaging and therapy. Their own "Theranostic Manufacturing Solutions" materials highlight experience producing radiolabeled mAbs for cancer imaging and treatment

ANSTO is Australia’s national nuclear science organisation and operates the OPAL research reactor, producing the majority of the country’s radiopharmaceuticals, including Mo-99/Tc-99m, I-131 and Lu-177 for domestic and regional use>

Pioneering the manufacture and development of targeted alpha‑emitting radionuclide cancer therapies, aiming to bring advanced, high‑precision treatments to oncology patients globally

A subsidiary of Orano Med since 2011, specializes in macrocyclic chelating agents—highly engineered ligands that securely bind radioactive metals like lead‑212 for use in diagnostic imaging and Targeted Alpha Therapy (TAT) in oncology.

A global radiotherapeutics company with a comprehensive pipeline of radionuclide drug conjugates, such as the PSMA-targeted 225Ac‑FL‑020 and NTSR1-targeted 177Lu‑FL‑091, across Belgium, Germany, and China

A U.S.-based radiopharmaceutical CDMO offering services for both diagnostic and therapeutic radiopharmaceuticals—especially theranostic agents such as Gallium‑68 DOTATOC and novel radio‑ligand therapies. The company supports product development from research through commercialization

An Australian-based, global leader in automated PET radiochemistry instrumentation and radiopharmaceutical development, offering products like the MultiSyn, F‑18 FlexLab, and HPLC+ that power efficient tracer synthesis and quality control

Develops targeted alpha‑emitting radiotherapies, such as Actimab‑A (CD33-targeted using Ac‑225), and ATNM‑400, a prostate cancer-directed antibody radioconjugate—both deeply rooted in theranostics

Capintec is a core nuclear medicine and molecular imaging instrumentation brand, focused on dose calibrators, well chambers, shielding, and related radiation measuring devices from radiopharmaceutical prep to patient administration.

BAMF Health brands itself as a highly integrated theranostics center combining molecular imaging, radiopharmaceutical therapy, and clinical trials under one roof.

Oncodesign Services is a CRO with deep pharmaco-imaging and radiochemistry/bioconjugation capability, including studies that leverage radioisotopes for biodistribution, tumor tracking, and biomarkers. That makes them directly useful for molecular radiotherapy and theranostics development programs that need preclinical imaging and translational support.

NCC Hospital East is publicly documented as a major national oncology hub with formal clinical research governance, supporting radiopharmaceutical/theranostic trial conduct through structured trial oversight.

PSI CRO offers pharmacokinetic and lab services for radiopharmaceutical theranostic trials in oncology, emphasizing on-time delivery. They manage global studies with PK expertise in targeted therapies.

Koç University Hospital is a modern academic hospital structure with a formal Nuclear Medicine department and clear leadership contact published online.

A global leader in diagnostic imaging . It plays a pivotal role in diagnostic imaging agents that enable theranostic approaches. Bracco acquired Blue Earth in 2019.

Avion is an Australian CRO with specialized imaging and radiopharma services, including management of radiopharmaceutical clinical trials, nuclear medicine imaging, and associated operational workflows.

Scientifically driven CRO & CDMO specialized in targeted radionuclide therapies, combining advanced oncology models and molecular imaging with development and manufacturing capabilities for radiopharmaceutical drug candidates. Strong fit for preclinical-to-early clinical theranostic programs

AACR's Patient Advocacy Program builds partnerships between advocates, survivors, and researchers, with the Cancer Molecular Imaging and Theranostics Task Force accelerating development of imaging and targeted therapies. It provides educational resources for patients on theranostic advance

Barnett International is a leading provider of clinical research training for over 40 years, offering comprehensive programs on GCP, regulatory affairs, site management, monitoring, data management, and budget/contracts through on-demand, live virtual, and on-site courses with certifications and CEUs.

A global contract research organization (CRO) formed by merger of Clinipace & dMed. Provides clinical trial development support and services

Dr. Oliver Sartor is a renowned medical oncologist and researcher specializing in prostate cancer since 1990, with expertise in theranostics, radiopharmaceutical therapies, and PSMA-targeted treatments like Lutetium-177 (Pluvicto). His research includes leading clinical trials such as the VISION trial for PSMA-targeted radioligand therapy, molecularly targeted radiation, and emerging therapies for neuroendocrine prostate cancer. He joined LCMC Health in 2025

A Chiliean pharmaceutical company (founded 2010) develops radiopharmaceuticals for molecular imaging—like 18F, NaF, 68Ga‑PSMA, and 68Ga‑DOTATATE—commonly used for PET scans in oncology

A global medical technology company specializing in molecular imaging, radiopharmaceuticals imaging tools, AI-driven dosimetry systems and through strategic ownership of other companies.

3P Biopharmaceuticals (now part of 3PBIOVIAN) is a biologics CDMO specializing in process development and cGMP manufacturing of recombinant proteins and mAbs.

IQVIA offers integrated laboratory and pharmacokinetic services for theranostic clinical trials, focusing on oncology with capabilities in biomarker analysis and data management for radiopharmaceuticals.

Labcorp provides comprehensive central laboratory services, including bioanalytical and pharmacokinetic testing, essential for oncology theranostic trials involving radiopharmaceuticals

A leader in clinical-stage radiopharmaceutical company pioneering Targeted Copper Theranostics (TCT) for both diagnostic imaging (64Cu) and therapeutic use (67Cu), powered by its proprietary SAR Technology platform

RDC is a long-running NVLAP-accredited dosimetry lab focused on personal radiation monitoring (badges, rings, fetal monitoring, etc.) for medical, dental, veterinary and other radiation-using practices.

An Israeli clinical-stage biotech pioneering Smart Targeted Radioligands (STRs) for precision oncology—theranostic compounds that both image and treat cancer by pairing disease-specific peptide targeting with therapeutic (alpha or beta) radiation delivery.

Led by Dr. Luke Nordquist, Medical Oncologist, Theranostic Key Opinion Leader, and CEO of XCancer, offering real-world insights and strategic guidance on the Theranostic Trials Ecosystem. Expertise centers on prostate cancer and the development of highly efficient, scalable, and robust Theranostic clinical trial programs and site networks.

Ameriflight is a dedicated cargo airline with extensive experience in radiopharmaceutical transport, ensuring safe and punctual delivery of theranostics materials across the US and Puerto Rico via specialized charters

Shared Imaging offers mobile and interim PET/CT systems, providing flexible diagnostic imaging access to support theranostic workflows in oncology settings

Sun Nuclear provides independent, integrated QA and dosimetry solutions used in more than 5,000 cancer centers worldwide, across RT and diagnostic imaging. Their QA platforms (e.g., SunCHECK) and dosimetry tools are used in centers implementing theranostic therapies

A global, research-driven pharmaceutical company founded in 1941 and headquartered in Tokyo, Japan. It focuses on developing innovative prescription medicines, especially in oncology

Creative Peptides is a custom peptide manufacturer that explicitly markets chelator-containing peptides (e.g., DOTAGA / DOTA conjugates) for radiolabeling and molecular imaging, directly targeting the radiopharmaceutical and theranostic market.

A clinical-stage radiopharmaceutical biotech company engineering highly specific, peptide-based radiotherapies for cancer—exemplifying theranostics by combining tumor-targeted delivery with potent radionuclide payloads (e.g., Lu-177, Ac-225)

A leader in radiopharmaceuticals and nuclear medicine, offering a broad product portfolio supported by decades of experience and a presence in over 60 countries

A Canadian nuclear energy company that also generates medical isotopes (used in diagnostics and radioisotope therapies), making it a key upstream player in the theranostics ecosystem

Bionomics is a U.S.-based licensed radioactive and mixed-waste broker headquartered in Tennessee, focused on turnkey pickup, packaging, transport, processing, and disposal of low-level radioactive and mixed wastes for medical, academic, industrial and government generators.

A leading global Contract Research Organization (CRO) that provides clinical research and regulatory consulting services to support biopharmaceutical and medical device companies in over 50 Countries

Develops precision-guided therapeutics, including biologics targeting challenging cancers; while not explicitly theranostic, their approach supports targeted therapeutic delivery

A global healthcare conglomerate active across pharmaceuticals, medical devices, and consumer health, with growing interest in radiopharmaceuticals and theranostics through various partnerships and research initiatives.

Heidelberg is one of Europe’s most influential academic clinical/research environments for nuclear medicine and radiopharmaceutical translation, with leadership that is heavily published in molecular imaging/therapy.

A global radiopharmaceutical company developing, manufacturing, and distributing diagnostic and therapeutic isotopes—particularly non-carrier-added Lu-177, Terbium-161, and Gallium-68 kits across Israel, Europe, and the U.S.

Alpha Nuclide is a commercial supplier and infrastructure builder for medical radioisotopes (notably At-211) and provides radiopharmaceutical R&D and manufacturing services that can support clinical trial supply. They position themselves across radionuclide supply, CRO-style development support, and GMP/clinical logistics, which are all the unglamorous but essential gears of the theranostics machine.

A China & U.S. based global CRO offering end-to-end clinical development services from Phase I to IV for pharmaceuticals, biologics, and medical devices

CLH’s Institute of Nuclear Medicine explicitly provides molecular radiotherapy services and supports a broad clinical nuclear medicine portfolio that feeds trial activity

Minute Medical is a specialized outpatient theranostics center focused on radioligand therapy and related molecular imaging, with an emphasis on prostate cancer (Lu-PSMA) and neuroendocrine tumors (Lu-DOTA-TATE/PRRT). The clinic publicly states its team has >1,000 Lu-PSMA treatments experience and >12 years with Lu-DOTA-TATE, and highlights being accredited as an EANM Theranostics Centre of Excellence (also noting renewed 2025 certification with inclusion of Tb-161)

A global Contract Research Organization (CRO) based in the U.S, that provides comprehensive outsourced clinical development and data solutions across all drug development phases, serving pharmaceutical, biotechnology, and medical device clients.

Standard Imaging provides QA, absolute and patient dosimetry solutions for radiation therapy and diagnostic CT/CBCT, widely used in cancer centers implementing advanced RT and imaging.

AMST specializes in manufacturing certified mobile and transportable medical imaging trailers, housing OEM PET/CT and other nuclear medicine scanners

Life Couriers (FKA Associated Couriers) is the global leader in radiopharmaceutical logistics, specializing in the secure and time-critical transport of theranostics agents from production sites to healthcare facilities worldwide. With over 45 years of expertise, the company manages the full chain of custody for radioactive materials

Proto Axiom, Australia's biotech incubator, invested in AdvanCell's actinium-based radioligands in 2025, retaining IP domestically for prostate cancer theranostics. Its $35M funding supports early-stage radiopharma, addressing supply chain gaps

Bristol-Myers Squibb is expanding its radiopharmaceutical portfolio through the acquisition of RayzeBio, with RYZ101 in development for gastroenteropancreatic neuroendocrine tumors and small cell lung cancer. Their focus on radiopharmaceutical therapy (RPT) aims to deliver targeted radioisotopes to tumors for precise cancer treatment

Atlantic Research Group delivers lab and pharmacokinetic services for oncology theranostic trials, focusing on rare diseases. They provide comprehensive CRO support including PK evaluations.

Sheba is a major tertiary center with strong nuclear medicine infrastructure and active participation in advanced molecular imaging that commonly underpins radioligand/theranostic trial pipelines

Ege University is a large academic medical faculty hospital with a formal Nuclear Medicine department and identifiable leadership, which is typically where theranostic programs (diagnostic PET/SPECT plus radioligand therapies) live and scale.

Worldwide Clinical Trials is a global mid-size CRO with strong oncology capabilities and a specific focus on radiopharmaceutical development, including dedicated scientific leadership and materials on radiopharmaceutical drug development strategy

This is a major academic nuclear medicine hub anchored at University of Pretoria / Steve Biko Academic Hospital, led by Prof Sathekge, with a strong track record in nuclear medicine research and clinical translation. NuMeRI functions as a nuclear medicine research infrastructure that explicitly supports clinical and theranostics operations and collaboration with external partners.

A U.S.-based expert in nuclear medicine logistics, MDS provides safe, compliant door-to-door transport of radiopharmaceuticals nationwide, serving nuclear pharmacies and diagnostic/therapeutic radiopharma shipping clients.

Dothan Hematology & Oncology is a community based medical oncology practice based in Dothan, Alabama, specializing in hematology and oncology services including a robust Theranostics Clinical Trial program in the XCancer Network.

A Swiss clinical-stage biotech company pioneering copper-based radiotheranostics, using Copper-61 for PET diagnostics and Copper-67 for targeted radiotherapy via its proprietary CuTrace™ platform, aiming to provide scalable, precise theranostic solutions across various cancers.

TD2 specializes in preclinical and clinical lab services for oncology theranostics, offering pharmacokinetic evaluations and biomarker analysis for radiopharmaceutical trials. They provide end-to-end support from model development to PK/PD studies, accelerating theranostic agent translation to clinic

Avidity Partners invests in healthcare growth-stage, with oncology exposure

BWXT Medical is a Canadian radiopharmaceutical and medical-isotope company. They manufacture and distribute a range of medical isotopes, including Mo-99/Tc-99m and emerging therapeutic isotopes such as Ac-225, supporting both commercial radiopharmaceuticals and clinical research

EDETEK offers the CONFORM platform for clinical informatics, data management, and EDC, supporting end-to-end digital solutions for pharmaceutical and biotech trials. It is involved in advanced oncology data management, providing tools for aggregated data validation and standards compliance suitable for theranostic studies requiring integration of multimodal data from diagnostics and therapeutics.

Developing targeted alpha therapies using Lead-212 (²¹²Pb), aimed at selectively destroying cancer cells with minimal impact on healthy tissue, and has an active industrial production platform.

A Saudi Arabian radiopharmaceutical manufacturer that specializes in producing and supplying diagnostic and therapeutic radiopharmaceuticals, including cyclotron operation, radionuclide therapy, and radiopharmacy services

RayzeBio, based in San Diego, focuses on precision radiopharmaceutical therapies using actinium-225 (Ac‑225), an alpha-emitting isotope, positioning itself as a leader in the next wave of cancer theranostics.

Project Farma focuses on planning and executing manufacturing facilities and capital projects for complex therapies, and explicitly positions itself around accelerating facility delivery. That aligns well with theranostics whenever the bottleneck is getting compliant space online faster (GMP support, operational readiness, expansion projects)

Eckert & Ziegler is a Berlin-based global provider of isotope technology with business segments dedicated to medical, research and industrial applications. In nuclear medicine they produce a broad range of radionuclides and sources

SRS is an international body that promotes the development and application of RLTs in medical imaging and theranostics. It holds conferences and offers education and networking opportunities for professionals in nuclear medicine and theranostics

A Healthtech software and services company based in Wisconsin. They specialize in patient‑specific radiopharmaceutical therapy (RPT) dosimetry, offering advanced AI‑driven software and professional dosimetry services for both clinical settings and clinical trials

Develops vendor‑neutral medical imaging software used across radiation oncology, radiology, nuclear and molecular medicine, interventional radiology, and neuro/cardiac imaging—helping streamline complex clinical workflows and improve personalized patient care

A U.S./Swiss preclinical-stage biotech developing the YB‑800 theranostics platform, including radiopharmaceuticals and diagnostics targeting novel tumor markers

AZI is a US-based organization focused on nuclear medicine, with operations designed to produce medical isotopes from reactor-based sources for both research and clinical use. Their core mission is to secure reliable supplies of key radionuclides used in diagnostic imaging and radiotherapy.

Main professional society for nuclear medicine in Australia and New Zealand. ANZSNM has a strong focus on training, accreditation across ANZ, heavily cited in global discussions about workforce & training in theranostics.

A Denmark‑based scientific Contract Research Organization (CRO) and Contract Development & Manufacturing Organization (CDMO) specializing in targeted radionuclide therapies, molecular imaging services, and translational research

Catalio focuses on breakthrough biomedical tech, raising $400M in 2025 for healthcare ventures

ADCO is one of the older U.S. low-level radioactive waste brokers/transporters, operating since 1965. They specialize in transportation and disposal of radioactive waste with services marketed to laboratories & hospitals, which aligns well with nuclear medicine & theranostic facilities needing sealed-source, collimator, and LLW disposal

Yale operates a theranostics initiative within the Section of Nuclear Medicine in Radiology and Biomedical Imaging, focusing on targeted radionuclide therapies for gastrointestinal malignancies and neuroendocrine tumors. Services include radioiodine, radium, and Lutathera (Lu-177 DOTATATE) therapies.

The Bracken Group is a consulting firm that explicitly calls out radiopharmaceuticals in its expertise and partners to support radiopharma programs, which commonly includes regulatory strategy and trial enablement work around theranostic pipelines.

JPT is a peptide specialist with strong activity in custom peptide libraries and GMP-grade peptides, including radiopharmaceutical and theranostic precursors such as PSMA-11 and other targeting peptides used in nuclear medicine trials. Their peptides are widely cited as precursors for radiolabeling in PET/SPECT imaging and targeted radionuclide therapy

A Swedish based global CRO that combines comprehensive clinical development services with flexible resourcing and Functional Service Provider solutions in Oncology and operates in more than 40 countries.

A precision oncology company leveraging next-generation antibody conjugation technologies & TRT to develop targeted cancer therapies

Bachem is one of the largest global peptide CDMOs and explicitly markets its expertise in peptides for molecular imaging and radiopharmaceuticals, including precursors used in peptide receptor radionuclide therapy (PRRT) and diagnostic tracers.

United Imaging manufactures digital PET/CT scanners used in theranostic centers for high-sensitivity oncology imaging and therapy response assessment

WARMTH is a worldwide nonprofit dedicated specifically to radionuclide molecular therapy and the “theragnostics/theranostics” paradigm, bringing together professionals focused on therapeutic nuclear medicine.

Pentixapharm develops CXCR4-targeted radiopharmaceuticals like PentixaFor for diagnostics and PentixaTher for therapy in oncology. In 2025, they presented new clinical findings at EANM, including first-in-human data for muscle-invasive bladder cancer treatment

CRB is a full-service facility design, engineering, construction, and consulting firm for the life sciences sector. That maps cleanly to theranostics whenever you're building GMP suites, QC labs, regulated warehouse space, or clinical manufacturing support areas used by radiopharma programs feeding trials.

UCSF integrates nuclear medicine molecular imaging with therapeutic delivery (molecular therapy) and routes patients into radiopharmaceutical-based treatment pathways and trials.

Thermo Fisher's radiation detection & measurement division provides survey meters, contamination monitors, area monitors and passive dosimetry. In nuclear medicine and theranostics, their instruments support radiation protection, environmental monitoring and dose tracking for facilities using radiopharmaceuticals

A clinical-stage oncology company pioneering targeted alpha therapeutics, using their proprietary Fast‑Clear™ linker technology to deliver alpha-emitting isotopes to tumors with improved safety and precision. In 2024 acquired by Astra Zeneca

A French CDMO offers turnkey technologies and supply chain solutions for the production and distribution of key theranostic radionuclides—including non-carrier-added Lutetium-177, Actinium-225, and Terbium-161

a regulatory/quality/safety consultancy with a dedicated Radiopharmaceutical Solutions offering that explicitly mentions theranostics, IND/CTA support, and navigating both drug + radiation regulatory complexity.

Mirion is a global provider of radiation detection and dosimetry solutions. Mirion Medical (Capintec, Sun Nuclear, Biodex) supplies dose calibrators, QA devices, and radiation monitors specifically for nuclear medicine, molecular imaging and radiation therapy.

Peter Mac is a premier oncology center in Australia with deep nuclear medicine/PET and radiopharmaceutical therapy expertise, widely recognized for clinical translation in imaging-to-therapy paradigms.

Scitech-EKIUM delivers consultancy, design/engineering, construction, and validation across regulated life-science sectors, including radiopharma. That makes them directly relevant when you're building or upgrading radiopharmaceutical production areas, controlled environments, and compliant spaces that feed theranostic trials.

CPDC is one of the original radiopharmaceutical CDMOs, focused on PET/SPECT and therapeutic agents, including n.c.a. Lu-177 supply and GMP manufacturing of radiopharmaceuticals.

Ratio Therapeutics (Boston) develops next‑generation small-molecule radiopharmaceuticals designed for theranostic use—able to accommodate both imaging and therapeutic radioisotopes—leveraging its Trillium™ targeting scaffold for precision oncology

ABX (Germany) manufactures and supports radiochemistry reagents, PET isotopes—such as precursors for nuclear medicine and radiopharmaceutical research—thus providing critical components for theranostic drug development

CPC Scientific is a global peptide & oligonucleotide CRDMO with extensive custom peptide capabilities, including peptides used in dually radiolabeled constructs for nuclear medicine and theranostic research

A innovative biotech incubator and umbrella company founded in 2018, specializing in next-generation radioligand therapies—particularly using Terbium-161—for prostate cancer and other tumor types as part of its theranostics portfolio

PPD, the clinical research business of Thermo Fisher, runs global radiopharmaceutical therapy trials and actively markets “extensive experience supporting complex radiopharmaceutical trials” and best practices for RLT studies.

A specialized conference series dedicated to advancing the development & clinical translation of targeted radiopharmaceuticals. With a strong focus on isotope supply chains, regulatory challenges, and innovative molecular design

Crown Bioscience is a preclinical oncology & immuno-oncology CRO whose platforms are used extensively for radiopharmaceutical and theranostic agent evaluation. They’ve partnered with Molecular Imaging / MDC

DMS Health delivers mobile PET/CT and nuclear medicine imaging services, facilitating diagnostic scans critical for theranostic patient evaluation and treatment planning in cancer care

RTW Investments backs life sciences innovation across the lifecycle, with a focus on transformative assets

Hacettepe is one of Turkey's best-known academic medical centers with dedicated oncology nuclear medicine and PET/SPECT infrastructure. Hacettepe University Hospitals It's also represented in theranostics research output (including Lu-177/PSMA-related work published with Hacettepe Nuclear Medicine affiliations).

Fortrea, as a full-service CRO, provides pharmacokinetic and laboratory services tailored for oncology theranostic trials, including support for radiopharmaceutical development and dosimetry. They leverage expertise in clinical operations to manage complex PK studies in targeted therapies.

A U.S. based, oncology-focused CRO that helps advance cancer therapies from preclinical stages through clinical trials to FDA approval, offering trial design, data management, flow cytometry, and medical/regulatory support

Robatel Technologies supplies shielded hot cells and gloveboxes for radiopharmacy, facilitating safe handling of therapeutic radioisotopes in oncology theranostics environments

EANM is the main nuclear medicine society in Europe and explicitly includes Oncology & Theranostics among its core committees. Its education arm, ESMIT, runs structured courses, webinars and e-learning, including content on radioligand therapy, dosimetry, and theranostic workflows.

Y‑mAbs is a commercial-stage biopharmaceutical company developing and commercializing novel radioimmunotherapies, centered around its Self‑Assembly DisAssembly Pre‑targeted Radioimmunotherapy (SADA‑PRIT) platform.

UHN/Princess Margaret is closely tied to radiotheranostics infrastructure through UHN-linked radiopharmaceutical programs (including GMP-aligned radiopharmaceutical support capacity) that enable investigational and clinical use.

A global pharmaceutical leader that actively develops and commercializes radioligand therapies, exemplified by its acquisition Endocyte (Pluvicto®) and of Mariana Oncology to strengthen its theranostics pipeline

LabConnect provides central lab and pharmacokinetic services for theranostic clinical trials, with expertise in radiopharmaceutical handling.

SNMMI is one of the main global professional societies in nuclear medicine and molecular imaging, with a growing focus on radiopharmaceutical therapy and theranostics. They are also involved in radiopharmaceutical therapy accreditation.

Engineers precision radiotherapeutics via its proprietary ROVEr™ platform, crafting antibody‑based agents with tunable pharmacokinetics to maximize tumor targeting while minimizing systemic toxicity—a strong theranostic approach

Clym is a healthcare-focused environmental services firm that provides radioactive, medical, mixed, and hazardous waste disposal plus decommissioning and safety services to hospitals, research labs, and life-science facilities.

ACRP is a non-profit organization providing rigorous training, certifications (e.g., CCRC, CCRA, ACRP-CP), and continuing education on clinical trial coordination, monitoring, regulatory affairs, data management, and ethics.

A Canadian specialized CDMO and leading developer of medical isotopes and radiopharmaceutical products—including Actinium-225, Lutetium-177, and Technetium-99m generators

A global pharmaceutical leader with extensive oncology and precision medicine pipelines and more recently involved with the development of Theranostic agents

A Belgian joint venture between IBA and SCK CEN focused on large-scale production of Actinium-225, a key alpha-emitting radioisotope used in theranostics for targeted cancer therapies—and has entered strategic agreements to supply Ac-225, such as with Bayer

DPR is a major builder with dedicated Life Sciences and Healthcare delivery, the exact intersection where theranostic trials live (imaging suites, infusion/therapy space, controlled support rooms). They're relevant when you need an experienced GC for complex, regulated clinical and technical builds.

A full‑service Contract Research Organization (CRO) with services in 40+ Countries

AFNMB is the main organization serving the nuclear medicine community across the Asia-Oceania region. AFNMB supports educational programs & conferences focused on theranostics.

POLATOM, part of the National Centre for Nuclear Research (NCBJ), is a manufacturer and distributor of medical and industrial radioisotope products, including Mo-99/Tc-99m generators, diagnostic kits, and multiple therapeutic radionuclides. Its product catalog includes I-131, Sr-89, P-32, Cr-51, Y-90 and Lu-177 for peptide labelling.

Eichrom supplies radiochemistry reagents and ion exchange resins extensively used in nuclear medicine and radiopharmaceutical research—crucial for theranostic development.

Gustave Roussy publicly highlights expansion into early-phase nuclear medicine trial capability, positioning it to run Phase I clinical trials connected to nuclear medicine/theranostic development.

Medpace provides full-service lab and pharmacokinetic support for radiation therapy and theranostic oncology trials. Their integrated approach includes dosimetry and PK modeling for radioligands

Cerba Research provides global specialty lab and pharmacokinetic services for oncology theranostics, with expertise in bioanalysis for radiopharmaceuticals. They support complex trials with integrated PK/PD and biomarker solutions across continents.

A molecular imaging company (a subsidiary of Bracco Imaging) that develops precision PET radiopharmaceuticals for cancer diagnostics, with a focus on agents like Axumin® and POSLUMA® for prostate cancer imaging using radiohybrid technology.

Brandon Capital's 2025 investments include AdvanCell's alpha-emitting radioligands for multiple cancers, bolstering Australia's radiopharma sovereignty. The firm's $439M fund targets biomedical breakthroughs, with theranostics as a key pillar for precision oncology

A global CDMO and radiopharmacy solutions provider dedicated to the full radiopharmaceutical lifecycle—from discovery and development through manufacturing, distribution, and commercialization of diagnostic imaging and therapeutic agents in support of theranostics. They operate an extensive network of facilities across the U.S., Canada, and Norway, and recently opened production/research sites in both New York's Bronx and Cincinnati

Actithera has developed a platform that maximizes radiation dose to tumor through covalent bonding. It is isotope agnostic.

Ariceum Therapeutics GmbH develops next-generation targeted radiopharmaceuticals to visualize and treat cancer, clearly aligning with theranostic approaches

PharmaLex publishes a dedicated radiopharma capability sheet and markets itself as a strategy + regulatory services provider for radiopharmaceutical programs.

A venture capital and private equity firm that partners with founders to build and scale transformative companies across physical industries—ranging from manufacturing and energy to healthcare infrastructure, robotics, and supply chain systems .Eclipse co-created Nucleus RadioPharma, a CDMO centered on radiopharmaceutical development

Charité’s Nuclear Medicine program is a major European academic engine for radiopharmaceutical imaging and therapy, supporting clinical translation and trials inside a top-tier university hospital ecosystem.

Focuses on a Necrosis Targeting Platform Technology (NTPT) for cancer imaging and targeted radiotherapy—key theranostic components aiming to both detect and treat tumors

a manufacturer of mobile and modular medical imaging units such as Mobile MRI, CT, PET/CT, and even transportable imaging trailers.

North America’s leading provider of waste collection, disposal, and recycling services, including hazardous waste management

IBA Dosimetry provides dosimetry systems for radiation therapy, particle therapy and medical imaging, including tools used in SPECT/PET environments and hybrid theranostic workflows. Their platforms & detectors are used to validate dose delivery and imaging performance.

An Austrian-based CDMO and analytical-services provider specializing in radiopharmaceutical development, production, and quality control—including the manufacture of therapeutic isotopes such as Lu‑177, Ac‑225, and F‑18

Ludlum designs and manufactures a broad range of radiation detection instruments, including survey meters, area monitors and specialized detectors used in nuclear medicine departments, hot labs, and radiopharmacy environments

Mayo publicly documents first-in-human administration of investigational theranostic radiopharmaceuticals and runs early-phase radiopharmaceutical therapy trials across Rochester, Phoenix, and Florida.

Clinigen is a global pharmaceutical services company specializing in clinical trial supplies, managed access programs, and radiopharmaceutical distribution. While primarily focused on supply chain and access rather than EDC, it supports theranostic trials by facilitating the sourcing and management of comparators and radiopharmaceuticals for oncology studies involving radioligands.

Marken provides precision logistics for radiopharmaceuticals, accelerating delivery of theranostics therapies through a global network that handles radioisotope shipments with expertise in customs and regulatory compliance. Specializing in patient-centric models, it enables direct-to-patient access for time-sensitive nuclear medicines.

ASTRO advocates for policies enhancing radiation oncology, including theranostics, and offers patient-focused resources on safe, effective radioligand treatments. Its advocacy efforts address payment reforms to improve access for cancer patients.

A Japanese company specializing in nuclear medicine imaging agents, actively involved in peptide-based theranostics and commercial-scale production of actinium‑225 for alpha therapies

Perma-Fix is a nuclear services company and a leading provider of radioactive and mixed waste management, specifically stating it manages radioactive and mixed waste for hospitals, research labs and institutions

Radionetics Oncology is a clinical-stage radiopharmaceutical company developing novel radiotherapeutics for oncology, built around the theranostic concept of pairing targeted radiation drugs with diagnostic imaging. They focus on discovering and advancing targeted radiopharmaceutical programs toward the clinic, aiming to expand the pipeline of precision radiotherapies across cancer indications.

The Theranostics World Congress is a dedicated global congress focused entirely on theranostics.

MD Anderson offers theranostics combining diagnostic imaging and targeted radionuclide therapy, approved for neuroendocrine tumors, prostate cancer, and thyroid cancer, with research expanding to other types. The RADIATE platform drives radiopharmaceutical discovery, including preclinical to clinical translation, with collaborations like the Radiopharm Ventures joint venture for novel agents targeting antigens like B7-H3.

Best Cyclotron Systems focuses on cyclotron facility needs, which is core infrastructure for PET isotopes and upstream radiopharma workflows that support theranostic ecosystems. If you're building/expanding isotope production capability or cyclotron-related infrastructure, they're in the conversation.

A non‑profit, public‑benefit organization dedicated to advancing theranostics for cancer care on a global scales through aising awareness, educating patients and healthcare professionals, supporting research and development, and improving access to these targeted treatments worldwide

A U.S. based Network of private practice centers specializing in Theranostics

A U.S.-based manufacturer of radioactive materials—including the only FDA-approved Sodium Iodide I‑131 drug product produced domestically—alongside calibration standards, cobalt-60 sealed sources, and isotope APIs for third-party theranostics developers

NeoGenomics delivers specialized oncology lab services, including molecular testing and pharmacokinetic support for theranostic clinical trials.

Lemer Pax designs shielded hot cells and injection systems specifically for high-energy radiopharmaceuticals like Ga-68 and Lu-177

RSNA is a major medical society focused on radiology and related fields, including nuclear medicine and molecular imaging. RSNA hosts the world’s largest annual radiology conference, including content on theranostics.

Istanbul Faculty of Medicine has published single-center clinical outcomes for Lu-177 PSMA radioligand therapy, reflecting active theranostic clinical practice and research.

Pan-European molecular imaging society covering basic, translational and clinical imaging science, including image-guided therapies and theranostics. Annual EMIM Conference involved Theranostic concepts

PolyPeptide Group is a focused global CDMO for peptide- and oligonucleotide-based APIs, and offers tailored solutions for radiolabeled peptides as part of its peptide CDMO portfolio. Their positioning as a peptide CDMO from pre-clinical through commercial fits well with supplying GMP theranostic peptide ligands

Cancer Focus Fund, in partnership with MD Anderson Cancer Center, invests in promising oncology therapies at Phase I/II stages, including radioligand and theranostic programs. It recently funded Starget Pharma's Phase 1b trial for a novel peptide radioligand theranostic targeting precision cancer therapy, providing capital and clinical trial expertise to advance targeted radionuclide treatments

A global pharma and life sciences company with a broad drug development portfolio in oncology with Radium 223 and including a growing pipeline of Theranostic Agents

Pharma (Japanese)

Orano TN specializes in nuclear materials transport, including casks and logistics for radiopharmaceutical precursors used in theranostics, with over 50 years of risk management expertise.

Bio X Cell is a specialist manufacturer of in vivo-grade monoclonal antibodies widely used as tools in immuno-oncology, imaging and experimental theranostics. Their antibodies include PSMA-targeted and checkpoint-targeted clones that are frequently used in preclinical radionuclide imaging

Zelta, formerly IBM Clinical Development and now under Merative, is a cloud-based EDC and clinical data management platform used in over 4,500 studies across therapeutic areas. It supports complex oncology trials, including those in precision medicine, with flexible modules for data capture that can accommodate the unique imaging and biomarker data needs in theranostic studies

venBio is a life sciences venture capital firm that invests in innovative biopharma companies, including those developing radiopharmaceuticals and theranostic approaches in oncology. It has backed RayzeBio (acquired by BMS), a leader in actinium-based radioligand therapies, and Abdera Precision, advancing antibody-drug conjugates and radiopharmaceuticals for targeted cancer treatment.

ORTEC is a global manufacturer of radiation detectors and nuclear instrumentation used in labs, nuclear facilities medical / research centers. In theranostics, ORTEC's spectrometry and detector systems are utilized on the research / radioisotope production and QA side than in frontline clinical hot labs.

IAOCR specializes in competence verification, accreditation, and training for clinical research professionals globally, offering programs to ensure staff meet industry standards in trial operations, GCP, and quality management. They provide certification pathways and organizational accreditation for excellence in clinical research.

TheranosticTrials.org connects patients, physicians, and clinics to global theranostic clinical trials, offering comprehensive lists and educational materials on radioligand therapies for cancer. It advocates for increased awareness and community engagement to provide hope through accessible trial opportunities.

A clinical-stage biotech firm developing a novel class of alpha radioligand therapies (ARTs)—a clear theranostic modality—using Pb‑212 and their proprietary AlphaDirect™ technology to enable targeted delivery with high efficacy and safety

Lytle Construction is a self-performing general contractor that explicitly specializes in healthcare construction including radiation shielding for molecular imaging facilities. They're relevant for hospital construction/renovation scopes tied to imaging and therapy delivery

Tigermed is a large China-origin global CRO that markets radiopharmaceutical development capabilities, including support from preclinical through phase I–IV, with services covering medical imaging, regulatory, data management and more.

A clinical-stage biotech company developing next-generation targeted radiotherapies—notably radioantibody platforms that harness alpha-particle radiation for precision cancer treatment

SK Biopharmaceuticals a global biotech based in South Korea and is active in radiopharmaceutical therapy, partnerships with KIRAMS for actinium-225 RPT and with Full-Life for the FL-091 radioligand.

An Irish global CDMO delivering end-to-end pharmaceutical services—from drug discovery, development, and API production to clinical trial support and diagnostics—including biomarker-driven precision medicine solutions, which are pivotal to theranostic strategies

An oncology CRO specializing in preclinical and clinical testing—including radiopharmaceutical testing and patient-derived tumor models—supporting theranostic drug development through real-world validation platforms

RPO Group explicitly brands itself as a radiotheranostic CRO, focused on early-phase clinical development of radiotheranostic agents.

A global leader in cyclotron technology & radiopharmaceutical manufacturing, supplying equipment

The Alliance integrates patient advocates into its committees, supporting theranostics in immuno-oncology and radiation trials for various cancers. It provides resources on clinical trials and advocates for innovative treatments like targeted radionuclides.

Viedoc is a modern eClinical platform with EDC at its core, designed for user-friendly data management in clinical trials across phases and therapeutic areas. It is particularly suited for oncology trials, supporting disease-specific forms for tumor assessments and adverse events critical in theranostic studies involving radioligands and targeted therapies.

Jacobs is a global solutions/engineering firm that supports complex facility programs and infrastructure, including advanced manufacturing type work that overlaps with regulated healthcare and life-science environments. They're relevant for theranostics when you need program-level engineering + delivery support across multiple sites or a heavily engineered build.

PCF is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. It has been a major driver of PSMA biology, imaging, and treatment research, and its scientific programs for prostate cancer.

A France-based software company specializing in personalized voxel-based dosimetry tools for radiation oncology and nuclear medicine, including the PLANET® platform that supports multi-radionuclide dosimetry across diagnostic and therapeutic workflows

Oppenheimer & Co. provides investment banking and advisory services in healthcare, including hosting oncology summits that feature radiopharmaceutical and theranostic innovations. While primarily an investment bank, it facilitates capital raising and partnerships for companies in the theranostics ecosystem, supporting financing for radioligand therapy trials and developments in precision oncology.

PCF is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. It has been a major driver of PSMA biology, imaging, and treatment research, and its scientific programs for prostate cancer.

NTP Radioisotopes SOC Ltd, a subsidiary of the South African Nuclear Energy Corporation (Necsa), is one of the world's leading producers of medical radioisotopes, supplying a significant share of global molybdenum-99 (for Tc-99m generators) as well as iodine-131 and lutetium-177 used in diagnostic imaging and radionuclide therapy

Eckert & Ziegler is one of the major global isotope technology companies, with a Radiopharma division that offers contract manufacturing and development of radiopharmaceutical APIs and finished products. They support a wide range of therapeutic radionuclides (including Lu-177 and Ac-225)

ABX-CRO specializes in lab and pharmacokinetic services for theranostic and radiopharmaceutical oncology trials, offering dosimetry and imaging support.

A global contract research organization (CRO) and functional service provider offering clinical development, resourcing, and quality services across multiple therapeutic areas, including oncology and diagnostics

Manufactures injectable radiopharmaceutical “cold kits” (e.g. Tc-99m kits) and other sterile parenterals, and operates as a contract manufacturer for radiopharmaceutical injectables within Sun’s broader sterile injectables CDMO offering.

A pioneering developer of high-definition, solid-state digital SPECT and SPECT/CT imaging systems—such as the ring-shaped VERITON-CT—that support theranostics applications by enabling precise imaging, dosimetry calculation, and treatment response monitoring using agents like Lu-177 PSMA

A full-service U.S.-based biopharmaceutical CDMO. Expertise in bioconjugation includes direct conjugation of Ac‑225 to monoclonal antibodies. They've also worked with other isotopes for theranostic applications, including Lu177, Zr‑89, In‑111, Bi‑213, Pb‑212

UPS Healthcare delivers end-to-end logistics and supply chain solutions tailored to pharmaceuticals, diagnostics, clinical trial logistics, and medical device delivery, making it suitable for theranostics and other sensitive healthcare shipments

Angstrom Technology engineers and delivers cleanroom solutions, which ties to theranostics through controlled environments used for radiopharmacy support, QC workflows, and other regulated buildouts.

A global contract research organization (CRO) based in the U.S. Provides oncology clinical trial services

A clinical-stage biotechnology company based in Houston, developing targeted radiopharmaceuticals and emphasizing a theranostic approach for cancer—supporting diagnosis, monitoring, and therapy with both alpha- and beta-labeled agents.

A global radiopharmaceutical CDMO based in Istanbul, supplying GMP-grade radioisotopes and theranostic radiopharmaceuticals—particularly high-specific-activity agents like Lutetium-177—across a robust logistics network serving over 70 countries.

A family-owned provider of medical imaging and therapeutic technologies, offering sales, service, consulting, education, and project management across modalities such as MRI, CT, ultrasound, nuclear/molecular imaging, and surgical systems

Syneos Health is an integrated biopharma solutions organization that includes a large oncology CRO unit with explicit experience in radiopharmaceutical studies.

Isotopia is a radiopharmaceutical company with significant CMO/CDMO-like services, specializing in isotopes and finished radiopharms, including Lu-177 and other therapeutic isotopes.

Landauer specializes in radiation safety, offering dosimetry services, medical physics consulting, and radiation monitoring tools—technologies essential for safe handling of theranostic radiopharmaceuticals

FedEx Custom Critical®, a Nuclear Medicine shipping service, which is specifically designed for the transport of short-lived radiopharmaceuticals used in PET, SPECT, and therapeutic applications. This service provides time-definite delivery, chain-of-custody security, and regulatory compliance for radioactive medical shipments

AirNet II provides 24/7 specialized air cargo for radiopharmaceuticals, focusing on compliant and secure transport of theranostics agents with direct routing to avoid sorting facilities.

venBio Partners invests in clinical-stage biotech, including oncology, and in 2025 supported Abdera Therapeutics' radiopharmaceutical pipeline for solid tumors via DLL3-targeting agents

Polimaster provides radiation detection equipment such as personal dosimeters, PRDs, portal monitors and handheld detectors. Hospitals and medical waste facilities working with radiopharmaceuticals use these devices for radiation control, access control and waste stream monitoring that indirectly supports safe theranostic practice.

A clinical biopharmaceutical company developing targeted radiotherapeutic agents using its proprietary Phospholipid Drug Conjugate (PDC™) platform, notably iopofosine (CLR‑131) and novel radioactive payloads for theranostic cancer treatments.

Exyte is an engineering/construction firm for high-tech facilities, explicitly covering Biopharma and Life Sciences at the board level. They're a fit when theranostic programs need GMP manufacturing, clean utilities, and controlled environments that support radiopharma supply chains and trial operations.

WMIS focuses on advancing molecular imaging and theranostics globally. Through its educational programs, scientific meetings, and publications, it serves as a platform for professionals involved in nuclear medicine, radiopharmaceuticals, and theranostics

A biotech company developing personalized radiopharmaceuticals designed to diagnose and treat aggressive cancers, with a focus on precision theranostic modalities

PTW is a long-standing global market leader in high-precision dosimetry and quality control solutions for radiation medicine, including RT and diagnostic imaging. Their ion chambers, phantoms, and QA systems are used to validate dose and imaging performance.

A Novartis subsidiary, is developing next-generation precision radioligand therapies to deliver targeted radiation treatments with minimized impact on healthy tissue including the target B7H3.

A clinical-stage Belgian biotech developing precision radiopharmaceuticals using camelid single-domain antibodies. Their platform enables theranostic pairing—first imaging, then therapeutic dosing using the same targeting molecule

A clinical-stage radioligand therapy company developing next-gen radioligand treatments for cancer. It was acquired by Eli Lilly in October 2023 to bolster their oncology portfolio.

Clean Harbors is one of the largest hazardous waste firms in North America. This includes programs that manage regulated medical waste "including radioactive" streams for hospitals and labs, which is directly relevant to PET/SPECT and theranostic radiopharmaceutical waste.

A healthcare investment firm (founded in 2015) that provides growth capital and strategic support to companies across the healthcare and life sciences sectors—including therapeutics, diagnostics, and related innovations

NELCO is a nuclear shielding specialist, which is not glamorous, but it's the difference between "operational hot lab" and "expensive concrete regret." They're directly relevant to theranostic trials because shielding is foundational for imaging rooms, radiopharmacy/hot labs, and therapy areas

An early-stage radiopharmaceutical company developing novel oncology agents for solid tumors.

A major pharmaceutical company headquartered in Indianapolis, expanding into radiopharmaceuticals and theranostics notably through the $1.4 billion acquisition of Point Biopharma, which bolsters its radioligand therapy capabilities

ALAMN serves as the representative body for nuclear medicine professionals in Latin America. The association focuses on the promotion of nuclear medicine and theranostics, supporting research and education in the application of radiopharmaceuticals

Comecer specializes in radiation shielding and isolation technology, providing hot cells, dispensers, and theranostic injectors essential for safe preparation and administration of radioligands in oncology theranostics programs.

Developing differentiated radiopharmaceutical therapies (RPTs) and companion diagnostics for hard-to-treat cancers, advancing theranostic agents such as ART‑101 (a PSMA-targeting radiotherapeutic) and a theranostic pair ARC‑706/ARC‑166

EMS is a national hazardous-waste company that specifically lists radioactive waste solutions, including materials like F-18 and Tc-99m from medical and pharmaceutical environments, and supports labs, hospitals, and healthcare facilities.

Oncodesign Services delivers preclinical pharmacokinetic and lab services for theranostic developments in oncology, including molecular radiotherapy. They support drug discovery with PK/PD studies for radioligands.

Regarding their theranostics program, Dothan Hematology & Oncology offers theranostics services at their Westside Drive facility, integrating it with PET/CT and SPECT/CT imaging for faster and more precise cancer diagnostics and treatment planning. This program supports their Alocent Clinical Trial Care initiative for advanced research in cancer therapies.

Chelatec is a preclinical CRO specialized in radiolabeling, ADME/PK and radiopharmaceutical non-clinical studies. They support radiopharmaceutical and theranostic development by providing custom radiolabeling

RaySafe focuses on X-ray radiation dosimetry and dose management, providing personal and area dosimeters, survey meters and integrated dose management tools. In theranostic centers, RaySafe equipment is often part of the radiation protection ecosystem around hybrid imaging suites (CT, fluoroscopy) and staff dose tracking.

Asta Bio is a biopharmaceutical company developing targeted radiotherapies by pairing Astatine-211 (alpha emitter) with proprietary Radiobody™ targeting molecules. It's theranostics in spirit and in practice: precision targeting plus potent radionuclide payloads aimed at hard-to-treat metastatic disease.

Monrol is a nuclear medicine company that operates as both a CMO and CDMO for radiopharmaceuticals, including extensive n.c.a. Lu-177 production. They provide early development support, fully integrated manufacturing services, and distribution across more than 50 countries

An immuno-oncology company developing radiotherapeutic and imaging agents targeting Glypican‑1 (GPC‑1) for solid tumors, with its lead candidate, Miltuximab®

A U.S.-based cyclotron and radiopharmaceutical technology company that provides compact cyclotron solutions and end-to-end manufacturing of diagnostics like therapeutic alpha radionuclides (Astatine-211, Actinium-225)

ABX-CRO is a specialized radiopharmaceutical and oABX-CRO is a specialized radiopharmaceutical and oncology CRO based in Dresden, providing full-service support across preclinical and clinical development for radiolabeled drugs.

Calyx delivers eClinical solutions, including EDC, medical imaging, and RTSM for clinical trials. They are involved in theranostics through strategic collaborations to accelerate the clinical translation of radioligand therapies, providing reliable data capture for imaging-intensive theranostic studies. Their services enhance the efficiency of trials involving targeted radionuclides and immuno-oncology agents.

Grupo RPH, also referred to as R2Pharma is a Brazilian radiopharmaceutical CDMO specializing in the production of cold kits and radiopharmacy solutions for diagnostic imaging. They operate the only privately owned GMP nuclear medicine manufacturing facility in Brazil and serve as the exclusive manufacturer and distributor for Telix's Gallium‑68 PSMA imaging kit (Illuccix®)

Shared Medical Services provides mobile PET/CT imaging solutions, delivering advanced diagnostic capabilities essential for patient selection and monitoring in oncology theranostics programs

A Norwegian CDMO, established in 2023 as a spin-off from the Institute for Energy Technology and partially owned by Pharmalogic, that specializes in the development, commercial-scale production, and global distribution of radiopharmaceutical therapies.

TCI is a large global lab-chemical manufacturer, but they are specifically referenced in theranostic literature and their own topics materials as a supplier of chelating scaffolds and building blocks, including NODAGA and other chelators relevant to radiometal-based theranostic radiopharmaceuticals

A radiopharmaceutical company focused on developing and delivering molecular diagnostics and therapeutics (theranostics). They manufacture and distribute PET imaging agents such as FDG, Pylarify (piflufolastat F-18), Neuraceq (florbetaben F-18), and others.

The ACR is a major professional organization that represents radiologists and related specialists, including those in the nuclear medicine and molecular imaging fields. It offers continuing education, training, and accreditation services related to the use of radiopharmaceuticals in theranostics

Messer is a large construction firm with regional offices and the kind of scale used for hospitals and complex facilities (the usual habitats of nuclear medicine and theranostic clinic buildouts).

Tata Memorial/ACTREC publicly outlines a dedicated theranostics program integrated into nuclear medicine services, positioning it as a high-volume regional anchor for theranostic care and trial participation.

Berthold develops instruments for biosciences, industrial process control and radiation protection, including dose-rate meters and monitoring systems for radioactive contamination and airborne activity. These are used in nuclear medicine, radiopharmacy, and research labs to monitor radiation levels, making them part of the safety infrastructure for theranostic centers

Qiming Venture Partners is a leading venture capital firm with a strong focus on healthcare investments across early and growth stages, including innovative oncology therapies. While primarily active in China and Asia with a US arm, it supports biotech companies advancing precision medicine, though direct theranostic investments are less prominent compared to broader oncology and radiopharma-adjacent portfolios

MTTI is a clinical-stage biotech developing targeted radiotherapeutics and diagnostics, i.e., the classic theranostics combo of "find it, then treat it." Their work centers on translating radiopharmaceutical and theranostic assets into clinical programs, supporting precision oncology approaches.

A major multinational healthcare services and product distributor. It manages pharmaceutical and medical product supply, including operating a vast radiopharmacy network that supports diagnostic and therapeutic agents essential for theranostics workflow

SpectronRx is a radiopharmaceutical CDMO and radiopharmacy network that develops, manufactures, and distributes diagnostic and therapeutic radiopharms.

A global, technology-enabled clinical research services provider formed from the merger of Calyx and Invicro. They deliver imaging biomarkers, eClinical solutions, clinical adjudication, and imaging core lab services with expertise in oncology

Biosynth is a global supplier of peptides and key biologics, with a dedicated theranostics services offering for radiopharmaceuticals. They highlight synthesis of radiolabeled peptide precursors and "smart peptide technologies" for theranostic applications,

A clinical-stage oncology company developing novel targeted cancer therapies across platforms such as immunotherapies, radioligand therapies, and antibody-drug conjugates, using proprietary memory B cell hybridoma technology to uncover underexplored targets